The Psoriatic Arthritis 5-Thermometer Scales (PsA-5Ts): Measurement Properties of a New Multidimensional Composite Tool for the Quick Assessment of the Overall Health Status in Psoriatic Arthritis

Overview

Journal J Pers Med

Date 2023 Jul 29

PMID 37511768

Authors

Fausto Salaffi

Marina Carotti

Sonia Farah

Marco Di Carlo

Affiliations

Soon will be listed here.

Abstract

Background: Psoriatic arthritis (PsA) is a heterogeneous condition that is difficult to assess. The goal of this research was to evaluate the clinimetric properties of the Psoriatic Arthritis 5-Thermometer Scales (PsA-5Ts), a new patient-reported outcome (PRO) to measure the overall health status in PsA patients.

Methods: The PsA-5Ts were compared to composite measures of disease activity (DAPSA, PASDAS, CPDAI) and PROs (PsAID-12 and SF-36). The convergent validity was assessed through the Spearman's correlation coefficient and the discriminant validity through the receiver operating characteristic (ROC) curve analysis, applying the Minimal Disease Activity (MDA) as an external criterion.

Results: The cross-sectional assessment included 155 patients. Significant high correlations were observed when comparing PsA-5Ts to composite indices of disease activity and PROs (all at significance levels of < 0.0001). The PsA-5Ts subscales were highly significantly different in terms of MDA status (all at < 0.0001). The PsA-5Ts had good discriminant validity like that of the DAPSA, CPDAI, PASDAS, and PsAID-12, and better than that of the SF-36, with an area under the ROC curve of 0.944 (65% CI 0.895-0.974).

Conclusions: The PsA-5Ts are an easy-to-use PRO that can be integrated with disease activity indices in the assessment of PsA in daily clinical practice.

References

Garrett S, Jenkinson T, Kennedy L, Whitelock H, Gaisford P, Calin A . A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994; 21(12):2286-91. View

Coates L, FitzGerald O, Mease P, Gladman D, Strand V, Goel N . Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11. J Rheumatol. 2014; 41(4):782-91. DOI: 10.3899/jrheum.131250. View

Gladman D, Mease P, Strand V, Healy P, Helliwell P, FitzGerald O . Consensus on a core set of domains for psoriatic arthritis. J Rheumatol. 2007; 34(5):1167-70. View

Krajewska-Wlodarczyk M, Owczarczyk-Saczonek A, Placek W . Fatigue - an underestimated symptom in psoriatic arthritis. Reumatologia. 2017; 55(3):125-130. PMC: 5534506. DOI: 10.5114/reum.2017.68911. View

Ware Jr J, Sherbourne C . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30(6):473-83. View

Nell-Duxneuner V, Stamm T, Machold K, Pflugbeil S, Aletaha D, Smolen J . Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis. Ann Rheum Dis. 2009; 69(3):546-9. DOI: 10.1136/ard.2009.117945. View

Schoels M, Aletaha D, Alasti F, Smolen J . Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis. 2015; 75(5):811-8. DOI: 10.1136/annrheumdis-2015-207507. View

Bhosle M, Kulkarni A, Feldman S, Balkrishnan R . Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006; 4:35. PMC: 1501000. DOI: 10.1186/1477-7525-4-35. View

Rothrock N, Kaiser K, Cella D . Developing a valid patient-reported outcome measure. Clin Pharmacol Ther. 2011; 90(5):737-42. PMC: 3753201. DOI: 10.1038/clpt.2011.195. View

10.

Sieper J, van der Heijde D, Landewe R, Brandt J, Burgos-Vagas R, Collantes-Estevez E . New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009; 68(6):784-8. DOI: 10.1136/ard.2008.101501. View

11.

Coates L, Mumtaz A, Helliwell P, Mease P, Callis-Duffin K, Krueger G . Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group. J Rheumatol. 2011; 38(7):1496-501. DOI: 10.3899/jrheum.110278. View

12.

Husted J, Gladman D, Farewell V, Cook R . Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum. 2001; 45(2):151-8. DOI: 10.1002/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T. View

13.

Fries J, Spitz P, Kraines R, HOLMAN H . Measurement of patient outcome in arthritis. Arthritis Rheum. 1980; 23(2):137-45. DOI: 10.1002/art.1780230202. View

14.

Coates L, Fransen J, Helliwell P . Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis. 2009; 69(1):48-53. DOI: 10.1136/ard.2008.102053. View

15.

Husted J, Tom B, Schentag C, Farewell V, Gladman D . Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis. 2008; 68(10):1553-8. DOI: 10.1136/ard.2008.098202. View

16.

Orbai A, de Wit M, Mease P, Shea J, Gossec L, Leung Y . International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2016; 76(4):673-680. PMC: 5344772. DOI: 10.1136/annrheumdis-2016-210242. View

17.

Poddubnyy D, Baraliakos X, Van den Bosch F, Braun J, Coates L, Chandran V . Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Ther Adv Musculoskelet Dis. 2022; 13:1759720X211057975. PMC: 8721378. DOI: 10.1177/1759720X211057975. View

18.

Apolone G, Mosconi P . The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998; 51(11):1025-36. DOI: 10.1016/s0895-4356(98)00094-8. View

19.

Benesh L, Szigeti E, Ferraro F, Gullicks J . Tools for assessing chronic pain in rural elderly women. Home Healthc Nurse. 1997; 15(3):207-11. DOI: 10.1097/00004045-199703000-00009. View

20.

Mumtaz A, Gallagher P, Kirby B, Waxman R, Coates L, Veale J D . Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis. 2010; 70(2):272-7. DOI: 10.1136/ard.2010.129379. View